INVESTOR RELATIONS

KAIROSmetics UG is currently open for a cooperation in the 8-Prenylnaringenin development line. The most developed products are the anti-ageing creme (working title: SKIN-PIN-FORTE) and the hormonal treatment of menopausal symptoms with or without a synthetic progestin (working title: AGEART and AGEART PLUS).
Other projects, which can be developed with very high probability of success are a vaginal preparation for the menopausal woman (working title: GYNGENIN) and low dosed chronic oral estrogen treatment of preferably elderly men for the prophylaxis of vessel injuries and bone substance loss and maintanance of libido (working title ARTECTION). The combination with a thrombocyte aggregation inhibitor ASA) is an additional extension of the product pipeline (ARTECTION COMP). While products in the dermal and gynecological fields need approvals from authorities, the planned dietary supplement or re-formulation products in the CV area do not.
We are open for any kind of investment, up to the complete transfer of individual projects or the complete area.
As the compound itself is not patentable anymore, IP will have to be generated as formulation/use patents by the investor.
The German protection right “Gebrauchsmuster” was applied for (all products).
If you are interested in a cooperation, please contact us.